Latest news with #daVinciSP
Maroc
11-07-2025
- Health
- Maroc
Moroccan Doctor Helps Pioneer Robotic Surgery in Spain
Ghali Belkahia, a young Moroccan physician who excels in the demanding world of high-precision urological surgery, recently contributed to the success of an unprecedented medical advancement in Europe. An internal resident in the Urology Department at ROC Clinic and HM Sanchinarro University Hospital in Madrid, Dr. Belkahia participated in the successful completion of the first robotic radical cystectomy performed with the da Vinci Single Port system in Spain. This technical feat had only been operated on twice before in Europe. Conducted as part of a latest-generation minimally invasive surgery program, this operation marks a turning point in the treatment of invasive bladder cancer, one of the most formidable in oncological urology, Dr. Ricardo Brime, head of the hospital's Robotic Surgery Unit, told MAP. Thanks to a single incision, the da Vinci SP robot allows access to complex anatomical areas while reducing risks, pain, and recovery times, he stressed. The young Moroccan surgeon described this advancement as a foundational experience for him, both humanly and professionally. "Participating in this innovative surgery means touching the future of medicine. It's experiencing from within a technological revolution that places patient safety and comfort at the center of the surgical act," he told MAP. It's also, according to him, a way to proudly represent Morocco in Europe's most advanced operating rooms, contributing to global medical excellence while remaining deeply attached to his roots. Trained at Complutense University of Madrid, and then holding a master's in medical knowledge integration from the Catholic University of Murcia, Dr. Belkahia embodies this generation of Moroccan doctors who combine rigorous training, scientific curiosity, and international openness. His career is already marked by several honorary distinctions: best scientific communication at the 14th National Congress of Health Sciences Students Research (2019), best prize at the 18th Congress of Biomedical Sciences in Madrid, and another prize at the CIOGEM International Congress in Gynecology and Obstetrics. "Dr. Ghali Belkahia, one of the team's most advanced residents, was entrusted with key steps in the urinary diversion during this complex intervention, testifying both to his high level of training and the confidence placed in him by the medical community," affirmed Dr. Vital Hevia, a specialist in uro-oncology. An active member of several renowned medical institutions, including the European Association of Urology (EAU), the Spanish Association of Urology (AEU), and the Illustrious Official College of Physicians of Madrid (ICOMEM), Dr. Belkahia also distinguishes himself through his commitment to sharing knowledge and transmitting best practices. His participation in this landmark operation once again illustrates the growing role played by Moroccans around the world in the fields of medical research and surgical innovation. Fortified by this experience acquired within a European reference center, the young Moroccan surgeon displays his determination to continue his journey in cutting-edge medical environments, while remaining attached to his roots and fully aware of the potential Moroccan doctors hold in health and surgical innovation. In a constantly changing medical world, Ghali Belkahia's name is now among those shaping the medicine of tomorrow, with humility and ambition. MAP: 10 July 2025
Ya Biladi
11-07-2025
- Health
- Ya Biladi
Moroccan doctor Ghali Belkahia pioneers robotic surgery breakthrough in Europe
Ghali Belkahia, a young Moroccan physician excelling in the demanding field of high-precision urological surgery, has recently contributed to a major medical breakthrough in Europe. As a resident in the Urology Department at ROC Clinic and HM Sanchinarro University Hospital in Madrid, Dr. Belkahia took part in the successful completion of Spain's first robotic radical cystectomy using the da Vinci Single Port (SP) system, an achievement only previously performed twice in Europe. This cutting-edge procedure was part of a next-generation, minimally invasive surgery program and marks a turning point in the treatment of invasive bladder cancer, one of the most challenging conditions in oncological urology, according to Dr. Ricardo Brime, head of the hospital's Robotic Surgery Unit. Thanks to a single incision, the da Vinci SP system offers access to complex anatomical zones while minimizing risk, pain, and recovery time, Dr. Brime noted. For Dr. Belkahia, the experience was both a personal and professional milestone. «Participating in such innovative surgery means touching the future of medicine», he told MAP. «It's about living a technological revolution from within, one that puts patient safety and comfort at the heart of surgical care». It also represents, he said, an opportunity to proudly represent Morocco in some of Europe's most advanced operating theaters, contributing to global medical excellence while staying deeply rooted in his heritage. Dr. Belkahia completed his medical training at the Complutense University of Madrid, followed by a master's degree in medical knowledge integration at the Catholic University of Murcia. He is part of a new generation of Moroccan doctors known for their rigorous training, scientific curiosity, and international outlook. His career is already decorated with several honors, including best scientific communication at the 14th National Congress of Health Sciences Students Research (2019), the top award at the 18th Congress of Biomedical Sciences in Madrid, and a distinction at the CIOGEM International Congress in Gynecology and Obstetrics. «Dr. Ghali Belkahia, one of our most advanced residents, was entrusted with key steps in the urinary diversion procedure during this complex operation, which speaks to both his high level of training and the confidence the medical team has in him», said Dr. Vital Hevia, a specialist in uro-oncology. An active member of several prestigious medical institutions, including the European Association of Urology (EAU), the Spanish Association of Urology (AEU), and the Illustrious Official College of Physicians of Madrid (ICOMEM), Dr. Belkahia is also committed to knowledge-sharing and the dissemination of best practices.
Yahoo
16-06-2025
- Health
- Yahoo
AdventHealth Tampa first in region to perform colorectal surgery using da Vinci SP robot
TAMPA, Fla., June 16, 2025 /PRNewswire/ -- AdventHealth Tampa is now the first hospital in the Tampa Bay region to successfully perform a transabdominal colorectal surgery using the da Vinci SP (single port) robot, taking the next step forward in providing minimally invasive colorectal procedures. The FDA recently approved this technology for colorectal surgeries, expanding the robot's use beyond its previously approved specialties of urology and head and neck procedures. Dr. Ahmed Allawi, colorectal surgeon at AdventHealth Tampa, performed a partial colectomy (bowel resection) using the SP robot. Before now, surgeons have only performed this procedure in Florida at a limited number of hospitals in Orlando and Miami. "Single port robotic surgery advances the benefits of conventional robotic surgery by allowing surgeons to operate through a single, small incision," Dr. Allawi said. "This not only minimizes scarring and post-operative pain but also reduces the risk of complications and speeds up recovery time. This offers patients a more efficient and cosmetically appealing surgical experience without compromising precision or control." The da Vinci SP robot enables surgeons to perform complex procedures through a single incision using a single-arm design that allows 360° access, along with better visibility, dexterity and accuracy, particularly in tight spaces such as the pelvis, where the colon is located. The use of the SP robot for colorectal procedures opens the door for further innovation in robotic-assisted gastrointestinal surgeries and showcases AdventHealth Tampa's ongoing commitment to adopting the latest advancements in surgical technology. For more information, visit or The Digestive Health Institute page. View original content to download multimedia: SOURCE AdventHealth West Florida Division Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10-04-2025
- Business
- Yahoo
Intuitive Surgical (NasdaqGS:ISRG) Gains FDA Clearance for Innovative SP SureForm 45 Stapler
Intuitive Surgical recently announced the FDA clearance of its SP SureForm 45 stapler for use with the da Vinci SP surgical system, an advancement set to enhance surgical procedures by increasing safety and efficiency. Despite the broader market facing a sharp decline, with the Nasdaq sliding 6% amid a tech rout, Intuitive's shares rose 8%, suggesting that the company's innovations and product approvals provided support against market pressures. While the broader market declined significantly due to various factors, including tariff uncertainties and technology sector volatility, Intuitive's recent developments may have contributed positively to its stock performance. Buy, Hold or Sell Intuitive Surgical? View our complete analysis and fair value estimate and you decide. Trump has pledged to "unleash" American oil and gas and these 20 US stocks have developments that are poised to benefit. Intuitive Surgical's recent FDA clearance for its SP SureForm 45 stapler signals potential enhancements in surgical procedures, likely boosting its operational efficiency and integration with the da Vinci SP system. This innovation may support revenue growth through increased adoption and system upgrades. Over the past five years, the company's total return, factoring in share price and dividends, was 207.02%, showcasing a significant long-term growth trajectory. In comparison, over the last year, Intuitive Surgical's performance exceeded both the US market and the Medical Equipment industry, which returned 4.7% and 1.8% respectively. The anticipated impact on revenue and earnings forecasts is promising, as strategic R&D investments and global approvals could elevate the company's market penetration and profitability. Revenue is currently forecasted to grow annually by 12%, while earnings are projected to expand by 12.8% per year. Intuitive Surgical's recent share price rise by 8% places it in context with an analyst price target of US$619.74, up 26.2% from its current value. Despite its high Price-To-Earnings Ratio compared to industry peers, the company's continued innovation and market expansion efforts could justify the target, depending on future earnings outcomes. Upon reviewing our latest valuation report, Intuitive Surgical's share price might be too optimistic. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:ISRG. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
